CBUS CIBUS INC

Cibus to Participate in Upcoming August Investor Events

Cibus to Participate in Upcoming August Investor Events

SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops plant traits to license to seed companies for royalties, today announced its participation in the following August investor events.

  • Canaccord Genuity 44th Annual Growth Conference, Boston, MA – August 13-14, 2024: Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, and Peter Beetham, Co-Founder, President, and Chief Operating Officer will host a presentation beginning at 12:30 p.m. ET (9:30 a.m. PT) on August 14.

Webcast link:

  • Sidoti Micro Cap Conference, Virtual – August 14-15, 2024: Mr. Riggs and Mr. Beetham, will be meeting with investors and host a virtual presentation beginning at 3:15 p.m. ET (12:15 p.m. PT) on August 14. A live audio webcast of the presentation will be accessible through the link below:

Webcast link:

About Cibus

Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop traits to license to seed companies in exchange for royalties on seed sales. Cibus' focus is productivity traits for farmers for the major global row crops with large acreage such as canola, corn, rice, soybean, and wheat. Cibus is a technology leader in high throughput gene editing technology that enables Cibus to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. In total, Cibus has developed a pipeline of six productivity traits. It is commercializing its Pod Shatter Reduction trait in Canola and is a leader in weed management traits in Rice with its HT1 and HT3 traits with customers such as Loveland Products (Nutrien Ltd.) and Interoc S.A in the United States and Latin America. Its recent development of stacked herbicide tolerant traits in rice is an important milestone in developing better weed solutions in rice. Its other pipeline traits including Sclerotinia resistance are in advanced greenhouse and field trial stages.

CIBUS CONTACTS:

INVESTOR RELATIONS

Karen Troeber



858-450-2636

Jeff Sonnek – ICR

MEDIA RELATIONS



(619) 849-6009

Colin Sanford



203-918-4347



EN
12/08/2024

Underlying

CBUSCIBUS INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CIBUS INC

 PRESS RELEASE
Free
CBUS CIBUS INC

Cibus Partnering with The John Innes Centre for UK Government’s Farmin...

Cibus Partnering with The John Innes Centre for UK Government’s Farming Innovation Programme Precision Breeding Initiative Cibus to utilize proprietary Rapid Trait Development System™ to enable development of durable resistance to Light Leaf Spot disease, which has caused estimated yield losses of up to £300m in recent years SAN DIEGO, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its participation as a key technology partner in...

February 6, 2026 1 EN
 PRESS RELEASE
Free
CBUS CIBUS INC

Cibus, Inc. Announces Pricing of $20.0 Million Public Offering of Clas...

Cibus, Inc. Announces Pricing of $20.0 Million Public Offering of Class A Common Stock SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the pricing of an underwritten public offering of 13,333,333 shares of its Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”), at a public offering price of $1.50 per share (the “Offering”). Members of Cibus’ Board of Directors will purchase 1,000,000 shares of Class...

January 29, 2026 1 EN
 PRESS RELEASE
Free
CBUS CIBUS INC

Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock

Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock SAN DIEGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that it intends to offer shares of its Class A common stock, par value $0.0001 per share (“Class A Common Stock”), in an underwritten public offering (the “Offering”). Cibus also expects to grant to the underwriter of the Offering a 30-day option to purchase up to an additional 15% of the shares of Class A...

January 28, 2026 1 EN
 PRESS RELEASE
Free
CBUS CIBUS INC

Cibus and Interoc Advance Rice Commercialization Strategy for Herbicid...

Cibus and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets across Latin America Nonbinding Letter of Intent (LOI) sets framework for potential 2027 market entry in Ecuador and Colombia, followed by expansion into Peru, Central America and the Caribbean Expected to build on success under the existing 2024 material transfer agreement, shifting focus to market execution and revenue generation for co-developed herbicide-tolerant (HT) rice traits SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technol...

January 5, 2026 1 EN
 PRESS RELEASE
Free
CBUS CIBUS INC

Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New...

Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and Council Political agreement on New Genomic Techniques (NGTs), including gene editing, advances a science-based path for plant breeding innovation and supports Cibus’ plans to bring improved traits to European growers The agreed legislative text outlining a framework for NGTs in the EU will now move to formal endorsement by the European Parliament and Council SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a lea...

December 11, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch